Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.
Abnormalities of chromosome 7q are common in myeloid malignancies, but no specific target genes have yet been identified. Here, we describe the finding of homozygous EZH2 mutations in 9 of 12 individuals with 7q acquired uniparental disomy. Screening of a total of 614 individuals with myeloid disord...
Prif Awduron: | Ernst, T, Chase, A, Score, J, Hidalgo-Curtis, C, Bryant, C, Jones, A, Waghorn, K, Zoi, K, Ross, F, Reiter, A, Hochhaus, A, Drexler, H, Duncombe, A, Cervantes, F, Oscier, D, Boultwood, J, Grand, F, Cross, N |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2010
|
Eitemau Tebyg
-
Inactivating mutations of the histone methyltransferase EZH2 in myeloid disorders
gan: Ernst, T, et al.
Cyhoeddwyd: (2010) -
INACTIVATING MUTATIONS OF THE HISTONE METHYLTRANSFERASE EZH2 ARE ASSOCIATED WITH CHROMOSOME 7 ABNORMALITIES IN MYELOID DISORDERS
gan: Ernst, T, et al.
Cyhoeddwyd: (2010) -
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms
gan: Thomas Ernst, et al.
Cyhoeddwyd: (2010-09-01) -
EZH2 in Myeloid Malignancies
gan: Jenny Rinke, et al.
Cyhoeddwyd: (2020-07-01) -
Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
gan: Su, I-hsin, et al.
Cyhoeddwyd: (2013)